Article

Lower SNAP Benefits May Increase ER Visits for Pediatric Asthma

Children with asthma were less likely to have an ER visit if their families received greater SNAP benefits than if their family received a smaller benefit.

Colleen M. Heflin, PhD

Colleen M. Heflin, PhD

One of the most damaging repercussions of poverty is having to choose between buying food and buying medication, a choice that far too many people have to make. It can be especially disastrous for those managing chronic diseases, such as asthma.

For a recent study, Colleen M. Heflin, PhD, Professor of Public Administration and International Affairs at Syracuse University, was interested in any links between the timing of SNAP (Supplemental Nutritional Assistance Program) benefits and emergency department treatment for childhood asthma. What she found was correlation between higher SNAP benefits and lower emergency department visits for asthma in children.

“There is evidence that participants in SNAP exhaust their benefits early in the month and often experience reduced food consumption at the end of the month,” Heflin told MD Magazine®. “I wanted to see if there were any observable health consequences to these monthly fluctuations in food consumption.”

According to the Centers for Disease Control and Prevention (CDC), one in 10 children under the age of 18 have asthma. The burden of asthma is highest on African-American children, who are 6 times more likely to die of asthma.

The Asthma and Allergy Foundation of America (AAFA) published their 2018 Asthma Capitals report, ranking the 100 largest cities where it is a challenge to manage asthma. The report also highlighted the 8 risk factors that can worsen asthma, which include poverty, lack of health insurance, and access to specialists.

For this study, Heflin and her colleagues evaluated SNAP participation patterns among children who were admitted to the ER for asthma using data from the Missouri Department of Social Services between January 2010 and December 2013. Only SNAP data linked to Medicaid claims for ER visits were included.

A child living in a household receiving $675 per month in benefits had a lower chance (5.43%) of going to the ER for an asthma exacerbation than a child living in a household receiving $275 per month (5.73%). Heflin says that these findings are surprising because households with higher SNAP benefits have fewer resources to draw upon and would be expected to be worse off with respect to health.

The generalizability of the findings is limited to states with a similar demographic composition to Missouri, which is slightly less diverse, in terms of the Hispanic population, than the national average.

“Our research does suggest that low-income households with children may not adhere to at-home treatments at the first sign of childhood respiratory distress in order to preserve financial resources for other essential needs, such as food,” said Heflin.

In the course of her research, Heflin said that she has found different relationships between SNAP benefit timing and benefit generosity with a number of disease conditions.

“It’s important to consider the role that within-month fluctuations in food consumption may have on adherence to medical protocols, disease progression, and healthcare utilization,” she said.

The study, “SNAP benefits and childhood asthma”, was published in Social Science and Medicine.

Related Videos
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Discussing Use of Vaping Among Students, Conversations About Vaccines
© 2024 MJH Life Sciences

All rights reserved.